Skip to main content
. 2019 Aug 20;322(7):632–641. doi: 10.1001/jama.2019.10931

Table. Characteristics of the Total Study Population (N = 47 045).

No. of Participants/
Total No. (%)a
Median (95% Range)
Maternal Demographics
Age, y 46 893 29.0 (5.2)b
Gestational age at blood sampling, wk 46 876 12.9 (7.0-39.7)
Body mass indexc 31 728 23.9 (4.4)b
Parity
0 24 180/44 336 (54.5)
1 13 217/44 336 (29.8)
2 4435/44 336 (10.0)
≥3 2504/44 336 (5.6)
Smoking status
Nonsmoker or past smoker 38 733/43 662 (88.7)
Current smoker 4929/43 662 (11.3)
Education leveld
Low 9677/31 574 (30.6)
Middle 10 647/31 574 (33.7)
High 11 250/31 574 (35.6)
Maternal Concentrations
Thyrotropin, mIU/Le 46 421 1.33 (0.13-4.52)
Free thyroxine, pmol/L 46 291 13.0 (7.2-21.9)
Thyroid peroxidase antibody positivity 3043/40 559 (7.5)
Thyroglobulin antibody positivity 1080/18 548 (5.8)
Pregnancy Characteristics
Gestational age at birth, wk 47 045 39.9 (35.3-42.0)
Sex
Male 18 936/37 355 (50.7)
Female 18 419/37 355 (49.3)
Late preterm birth (gestational age <37 wk)f 2357/47 045 (5.0)
Early preterm birth (gestational age <32 wk) 349/47 045 (0.7)

SI conversion factor: To convert free thyroxine to ng/dL, divide by 12.871.

a

The total No. indicates the No. of participants with available data on the thyroid function tests. Cohort-specific descriptive characteristics appear in eTable 1 in Supplement 2.

b

Expressed as mean (SD).

c

Calculated as weight in kilograms divided by height in meters squared.

d

Defined as estimated years of education beyond primary school (low: 0-4 years; middle: 4-8 years; high: >8 years).

e

Often referred to as thyroid-stimulating hormone or TSH.

f

Includes very preterm birth (<32 weeks’ gestational age).